We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
+22.32%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215B
AUM Growth
+$28.1B
(+15%)
Cap. Flow
+$1.96B
Cap. Flow
% of AUM
0.91%
Top 10 Holdings %
Top 10 Hldgs %
41.33%
Holding
3,754
New
71
Increased
744
Reduced
1,650
Closed
116
Avg Time Held
1
quarter
Top 10 Avg Time Held
1
quarter
Top 20 Avg Time Held
0.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$688M |
| 3 |
Marvell Technology
MRVL
|
+$294M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$214M |
| 5 |
Royal Bank of Canada
RY
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$189M |
| 2 |
Honeywell
HON
|
+$157M |
| 3 |
Apple
AAPL
|
+$124M |
| 4 |
Microsoft
MSFT
|
+$89M |
| 5 |
Amazon
AMZN
|
+$62.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.83% |
| 2 | Miscellaneous | 25.2% |
| 3 | Financials | 11.43% |
| 4 | Communication Services | 6.64% |
| 5 | Consumer Discretionary | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Newmark Group
NMRK
$2.29B
| $915K | ﹤0.01% |
60,576
-2,783
| -4% | -$42.5K |
2026 Q1
1 quarter
|
|
1802
Nektar Therapeutics
NKTR
$1.6B
| $915K | ﹤0.01% |
13,104
+1,850
| +16% | +$135K |
2026 Q1
1 quarter
|
|
1803
Taysha Gene Therapies
TSHA
$1.54B
| $911K | ﹤0.01% |
133,821
+17,130
| +15% | +$101K |
2026 Q1
1 quarter
|
|
1804
Alarm.com
ALRM
$2.69B
| $911K | ﹤0.01% |
19,500
-571
| -3% | -$25.6K |
2026 Q1
1 quarter
|
|
1805
Collegium Pharmaceutical
COLL
$711M
| $911K | ﹤0.01% |
25,153
+3,245
| +15% | +$111K |
2026 Q1
1 quarter
|
|
1806
TriCo Bancshares
TCBK
$1.66B
| $904K | ﹤0.01% |
16,782
+371
| +2% | +$18.8K |
2026 Q1
1 quarter
|
|
1807
Talos Energy
TALO
$2.78B
| $902K | ﹤0.01% |
69,871
+21,098
| +43% | +$315K |
2026 Q1
1 quarter
|
|
1808
Iovance Biotherapeutics
IOVA
$6.45B
| $900K | ﹤0.01% |
216,401
+82,564
| +62% | +$314K |
2026 Q1
1 quarter
|
|
1809
PagSeguro Digital
PAGS
$2.44B
| $899K | ﹤0.01% |
99,341
+31,373
| +46% | +$303K |
2026 Q1
1 quarter
|
|
1810
Nabors Industries
NBR
$1.21B
| $898K | ﹤0.01% |
10,695
+2,256
| +27% | +$210K |
2026 Q1
1 quarter
|
|
1811
Nurix Therapeutics
NRIX
$2.42B
| $898K | ﹤0.01% |
37,035
| – | – |
2026 Q1
1 quarter
|
|
|
MZTI
1812
The Marzetti Company
MZTI
$2.72B
| $898K | ﹤0.01% |
7,870
-298
| -4% | -$35.8K |
2026 Q1
1 quarter
|
|
1813
Hawaiian Electric Industries
HE
$1.55B
| $897K | ﹤0.01% |
66,276
-2,618
| -4% | -$37.3K |
2026 Q1
1 quarter
|
|
1814
FIGS
FIGS
$2.34B
| $896K | ﹤0.01% |
87,546
+7,417
| +9% | +$97.5K |
2026 Q1
1 quarter
|
|
1815
Transmedics
TMDX
$2.73B
| $891K | ﹤0.01% |
13,421
-1,174
| -8% | -$99.4K |
2026 Q1
1 quarter
|
|
1816
Navient
NAVI
$854M
| $890K | ﹤0.01% |
104,629
+58,301
| +126% | +$490K |
2026 Q1
1 quarter
|
|
1817
Choice Hotels
CHH
$4.6B
| $888K | ﹤0.01% |
8,053
-340
| -4% | -$37.6K |
2026 Q1
1 quarter
|
|
1818
Entravision Communication
EVC
$681M
| $887K | ﹤0.01% |
68,027
+41,699
| +158% | +$296K |
2026 Q1
1 quarter
|
|
1819
Levi Strauss
LEVI
$7.67B
| $881K | ﹤0.01% |
35,501
-3,673
| -9% | -$82.8K |
2026 Q1
1 quarter
|
|
|
UNIT
1820
Uniti Group
UNIT
$1.93B
| $879K | ﹤0.01% |
76,607
+6,088
| +9% | +$69.1K |
2026 Q1
1 quarter
|
|
1821
Calix
CALX
$2.2B
| $874K | ﹤0.01% |
23,406
-1,206
| -5% | -$50.6K |
2026 Q1
1 quarter
|
|
1822
Stoke Therapeutics
STOK
$1.68B
| $872K | ﹤0.01% |
26,639
| – | – |
2026 Q1
1 quarter
|
|
1823
Gentherm
THRM
$1.03B
| $871K | ﹤0.01% |
25,537
+191
| +0.8% | +$6.15K |
2026 Q1
1 quarter
|
|
1824
Holley
HLLY
$289M
| $869K | ﹤0.01% |
340,868
+233,191
| +217% | +$662K |
2026 Q1
1 quarter
|
|
1825
Pebblebrook Hotel Trust
PEB
$2.12B
| $868K | ﹤0.01% |
44,720
-43
| -0.1% | -$663 |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Global Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Global Advisers held 3,754 positions worth $215B, up 15% from $187B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Global Advisers opened 71 new positions and exited 116, leaving the 3,754-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Miscellaneous and Financials.
- Vanguard Global Advisers's largest Q2 2026 buy was Honeywell Aerospace: 682,434 shares worth $151M.
- Vanguard Global Advisers added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.11B increase.
- Vanguard Global Advisers's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $189M.
- Vanguard Global Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $58.2M.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $215B portfolio in Q2 2026.
- Vanguard Global Advisers opened 71 new positions and closed 116 in Q2 2026.
- Vanguard Global Advisers's portfolio value rose 15% quarter-over-quarter to $215B.
Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.